Try our Advanced Search for more refined results
January 16, 2013
UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. et al
Case Number:
3:13-cv-00316
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 03, 2014
Sandoz Gets Claims Nixed In UTC's Generic Remodulin Fight
A New Jersey federal judge overseeing United Therapeutics Corp.'s patent litigation over Sandoz Inc.'s proposed generic version of hypertension drug Remodulin, on Monday tossed both parties' claims regarding one of the three at-issue patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login